Hybio Pharmaceutical Co., Ltd. (SZSE:300199) agreed to acquire 10.81% stake in Hybio Biotechnology (Dali) Co., Ltd. from Dazhong Transportation (Group) Co., Ltd. (SHSE:600611) for CNY 20 million on May 10, 2022. After the repurchase is completed, Hybio Pharmaceutical will hold 69.22% of Hybio Biotechnology. As on December 31, 2021, Hybio Pharmaceutical reported total assets of approximately CNY 110 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.88 CNY | +5.31% | +5.92% | -5.15% |
1st Jan change | Capi. | |
---|---|---|
-5.15% | 1.57B | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.32% | 13.79B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- 300199 Stock
- News Hybio Pharmaceutical Co., Ltd.
- Hybio Pharmaceutical Co., Ltd. agreed to acquire 10.81% stake in Hybio Biotechnology Co., Ltd. from Dazhong Transportation Co., Ltd. for CNY 20 million.